Sci-Tech World Delaware: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech World Delaware.

Press releases published on November 12, 2026

Nov. 12, 2026

Relmada Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 12, 2026

Dyadic Announces Third Quarter 2026 Financial Results and Recent Developments

Indeterminate GlobeNewswire

Nov. 12, 2026

Iovance Biotherapeutics to Present at Upcoming Conference

Indeterminate GlobeNewswire

Nov. 12, 2026

Akari Therapeutics Reports Third Quarter 2026 Financial Results and Highlights Continued Progress Toward Clinical Development of Differentiated ADC Payload Platform

Indeterminate GlobeNewswire

Nov. 12, 2026

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 12, 2026

ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2026

Indeterminate GlobeNewswire

Nov. 12, 2026

ROC Delivers Record Quarterly Revenue of $8.0 Million in the Third-Quarter 2026, Up 50% YoY; Achieves Quarterly Profitability

Indeterminate GlobeNewswire

Nov. 12, 2026

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 12, 2026

Erasca Reports Third Quarter 2026 Business Updates and Financial Results

Indeterminate GlobeNewswire

Nov. 12, 2026

Biomea Fusion to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 12, 2026

Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire

Nov. 12, 2026

Electra Therapeutics Reports Third Quarter 2026 Financial Results and Recent Portfolio Highlights

Indeterminate GlobeNewswire

Nov. 12, 2026

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2026 Financial Results and Provide Corporate Update

Indeterminate GlobeNewswire

Nov. 12, 2026

MacroGenics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate Progress

Indeterminate GlobeNewswire

Nov. 12, 2026

Mdxhealth Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 12, 2026

Oragenics Receives NYSE American Approval of Compliance Plan and Extension Through February 2028

Indeterminate GlobeNewswire

Nov. 12, 2026

Assembly Biosciences Reports Third Quarter 2026 Financial Results and Recent Updates

Indeterminate GlobeNewswire

Nov. 12, 2026

WebWork Time Tracker Expands Productivity Insights With KPIs per Job Title, Set by WebWork AI

Indeterminate EIN Presswire

Nov. 12, 2026

Cribl Named to Inaugural 2026 AI 100 List

Indeterminate GlobeNewswire

Nov. 12, 2026

Cyclarity Therapeutics Receives FDA Investigational New Drug Clearance for UDP-003 to expand Atherosclerosis Clinical Development Program into the United States

Indeterminate GlobeNewswire